Thirty-Day Mortality Following Systemic Anticancer Therapy: Evaluating Risk Factors Without Selection Bias in a Real-World, Population-Based Cohort From 2009 to 2019
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology
Reference25 articles.
1. Hallmarks of cancer: the next generation;Hanahan;Cell,2011
2. Cardiac side-effects from breast cancer radiotherapy;Taylor;Clin Oncol,2015
3. Cardiovascular and renal toxicity during angiogenesis inhibition: clinical and mechanistic aspects;Kappers;J Hypertens,2009
4. Curtailing side effects in chemotherapy: a tale of PKCδ in cisplatin treatment;Pabla;Oncotarget,2012
5. Drugs, cancer and end-of-life care: a case study of pharmaceuticalization?;Davis;Soc Sci Med,2015
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Utility of 30-Day Mortality Following Systemic Anti-Cancer Treatment as a Quality Indicator in Advanced Lung Cancer;Clinical Lung Cancer;2024-07
2. Risk factors prediction of 6-month mortality after noncardiac surgery of older patients in China: a multicentre retrospective cohort study;International Journal of Surgery;2023-09-21
3. Feasibility and early clinical impact of precision medicine for late-stage cancer patients in a regional public academic hospital;Acta Oncologica;2023-03-04
4. Real World Data – Does it Cut the Mustard or Should We Take it With a Pinch of Salt?;Clinical Oncology;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3